Literature DB >> 2165443

Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3.

Y Seko1, H Tsuchimochi, T Nakamura, K Okumura, S Naito, K Imataka, J Fujii, F Takaku, Y Yazaki.   

Abstract

Evidence has accumulated that T cell-mediated autoimmunity plays an important role in the pathogenesis of viral myocarditis. T lymphocytes are known to recognize antigen-presenting cells, such as virus-infected cells, being restricted by syngeneic major histocompatibility complex (MHC) antigens. To clarify in more detail the immunological mechanisms involved, we induced acute viral myocarditis in C3H/He mouse ventricles with coxsackievirus B3 (CVB3) and examined, by immunofluorescence, the expression of MHC class I and II antigens, previously reported not to be expressed by normal cardiac myocytes. Furthermore, to confirm the expression of MHC class I (H-2Kk) antigens at the cellular level, we treated cultured cardiac myocytes with interferon gamma and examined the antigen expression by immunofluorescence and Northern blot hybridization, using an antisense RNA probe for MHC messenger RNA. Our observations demonstrated 1) CVB3-induced myocarditis resulted in the enhanced expression of MHC class I (H-2Kk) gene product on the surface of cardiac myocytes but low or undetectable levels of MHC class II or H-2Dk gene products, and moderate focal transient (days 5-7) expression of both MHC class I (Kk + Dk) region gene products and MHC class II antigens were induced on capillary endothelial cells; 2) murine fetal cardiac myocytes cultured in vitro in the presence of interferon gamma similarly were shown to express marked levels of MHC class I (H-2Kk) but low to undetectable levels of the H-2Dk gene product; however, weak to moderate MHC Class II antigens were expressed by these cultured myocytes; and 3) the expression of MHC antigens in cardiac myocytes was modulated at the transcriptional level.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165443     DOI: 10.1161/01.res.67.2.360

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Intracellular viral localization in murine coxsackievirus-B3 myocarditis. Ultrastructural study by electron microscopic in situ hybridization.

Authors:  A Ukimura; H Deguchi; Y Kitaura; S Fujioka; M Hirasawa; K Kawamura; K Hirai
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 2.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 3.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

4.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

5.  Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.

Authors:  Y Seko; H Matsuda; K Kato; Y Hashimoto; H Yagita; K Okumura; Y Yazaki
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy.

Authors:  Y Seko; S Ishiyama; T Nishikawa; T Kasajima; M Hiroe; N Kagawa; K Osada; S Suzuki; H Yagita; K Okumura
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle.

Authors:  Michael Didié; Satish Galla; Vijayakumar Muppala; Ralf Dressel; Wolfram-Hubertus Zimmermann
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

9.  Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis.

Authors:  Seulgi Choi; HyeLim Park; SeoYeon Jung; Eun-Kyung Kim; Mi-La Cho; Jun-Ki Min; Su-Jin Moon; Sang-Myeong Lee; Jang-Hee Cho; Dong-Hee Lee; Jae-Hwan Nam
Journal:  Int J Mol Sci       Date:  2017-09-14       Impact factor: 5.923

10.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.